somatostatin analogue
Octreotide clinical trials
Answer
Octreotide has 344 registered trials: 50 running, 192 completed, 52 stopped early. 67 posted results.
Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT02019706 Trial register | Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome | currently recruiting participants | - | 2013-12-24 | - |
| NCT00569127 Trial register | Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor | running, but no longer enrolling | - | 2007-12-06 | Posted |
| NCT07583563 Trial register | An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly | currently recruiting participants | - | 2026-05-13 | - |
| 2024-516616-24-00 Trial register | A Phase 3 randomized 3-arm trial (double-blind Debio 4126, placebo control, and open-label Debio 4126), to assess the efficacy and safety of Debio 4126, a 12-we | Not stated | 3 | - | - |
| 2023-507443-10-00 Trial register | A phase III multi-center, randomized, open-label study to evaluate the efficacy and safety of Lutathera in patients with Grade 2 and Grade 3 advanced GEP-NET (N | Not stated | 3 | - | - |
| 2024-519667-18-00 Trial register | Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and te | Not stated | 4 | - | - |
| NCT06878664 Trial register | Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors | currently recruiting participants | - | 2025-03-17 | - |
| NCT07663318 Trial register | A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Oct | completed | - | 2026-06-23 | - |
| NCT06784752 Trial register | Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET | currently recruiting participants | - | 2025-01-20 | - |
| NCT07814651 Trial register | A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly | completed | 2 | 2026-09-11 | - |
| NCT06592261 Trial register | Graded Insulin Suppression Test P&F | currently recruiting participants | - | 2024-09-19 | - |
| 2023-509334-19-00 Trial register | Trial title: Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects with inop | Not stated | 3 | - | - |
| 2023-503613-29-00 Trial register | Efficacy and safety of octreotide in laparoscopic hepatectomy surgery: effect on blood loss, need for vasoactive drugs, transfusion requirement. | Not stated | 2 | - | - |
| NCT06930625 Trial register | A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs | currently recruiting participants | - | 2025-04-09 | - |
| NCT04076462 Trial register | A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly | completed | - | 2019-09-03 | Posted |
| 2023-508723-12-00 Trial register | A randomized, multi-center, open-label, active-controlled Phase 3 trial to assess the efficacy and safety of octreotide subcutaneous depot (CAM2029) versus octr | Not stated | 3 | - | - |
| NCT03049189 Trial register | Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients | running, but no longer enrolling | - | 2017-01-13 | Posted |
| NCT06441331 Trial register | Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors | currently recruiting participants | - | 2024-05-22 | - |
| NCT07087054 Trial register | Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | currently recruiting participants | - | 2025-07-09 | - |
| NCT05050942 Trial register | A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET | running, but no longer enrolling | - | 2021-09-21 | - |
| NCT00113360 Trial register | RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma | completed | - | 2005-06-08 | Posted |
| NCT07403604 Trial register | Effect of Insulin Lowering on Lipogenesis | currently recruiting participants | - | 2026-02-04 | - |
| 2023-505884-35-00 Trial register | Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with long-acting Somatostatin Analogues - ATSA trial | Not stated | 4 | - | - |
| NCT06326190 Trial register | 177Lu-DOTATATE for Recurrent Meningioma | currently recruiting participants | - | 2024-03-14 | - |
| NCT07623824 Trial register | A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly | not yet recruiting participants | - | 2026-06-03 | - |
| NCT05281328 Trial register | A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD | running, but no longer enrolling | - | 2022-03-16 | Posted |
| NCT05884255 Trial register | An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. | currently recruiting participants | - | 2023-06-01 | - |
| NCT05918302 Trial register | Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. | currently recruiting participants | - | 2023-03-06 | - |
| NCT06240039 Trial register | Direct Versus Indirect Effect of Amino Acids on Hepatokines | running, but no longer enrolling | - | 2024-02-02 | - |
| NCT01744249 Trial register | Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas | completed | - | 2012-09-25 | Posted |
| 2024-518325-15-00 Trial register | A phase III multi-center, randomized, open-label study to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE in patients newly diagnosed with Grade 1 and G | Not stated | 3 | - | - |
| NCT07165886 Trial register | Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors | currently recruiting participants | - | 2025-09-10 | - |
| NCT07534371 Trial register | Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study | running, but no longer enrolling | - | 2026-04-08 | - |
| NCT05153772 Trial register | Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients | running, but no longer enrolling | - | 2021-11-04 | - |
| 2024-519183-40-00 Trial register | Receptor radionuclide therapy with 177Lu-DOTATOC (177Lu- edotreotide or 177Lu-octreotide) in SSTR positive patients: a multicenter, prospective, phase II trial | Not stated | 2 | - | - |
| NCT05749289 Trial register | Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression | currently recruiting participants | - | 2023-03-01 | - |
| NCT05477576 Trial register | Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy | currently recruiting participants | - | 2022-07-28 | - |
| NCT07255248 Trial register | Hoffa's Fat Pad Impingement (HFPI) | currently recruiting participants | - | 2025-11-28 | - |
| NCT05361668 Trial register | Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome | completed | - | 2022-04-27 | Posted |
| 2024-515636-77-00 Trial register | An exploratory study of [18F]AlF-NOTA-octreotide high resolution NeuroEXPLORER PET and MRI in carotid artery disease | Not stated | 2 | - | - |
| NCT07479784 Trial register | Octreotide Microspheres for Preventing Pancreatic Fistula | not yet recruiting participants | - | 2026-03-18 | - |
| 2023-505313-24-00 Trial register | A randomized, placebo-controlled, double-blind, multi-center trial to assess efficacy and safety of octreotide subcutaneous depot (CAM2029) in patients with sym | Not stated | 2/3 | - | - |
| NCT07460908 Trial register | Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome | completed | - | 2026-03-10 | - |
| NCT03879694 Trial register | Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors | completed | - | 2019-03-19 | - |
| NCT06558422 Trial register | Human Models of Selective Insulin Resistance: Pancreatic Clamp | not yet recruiting participants | - | 2024-08-16 | - |
| 2024-513443-93-00 Trial register | EORTC 2334-BTG: [177Lu]Lu-DOTATATE for recurrent MENingioma (LUMEN-1): a randomized phase II study | Not stated | 2 | - | - |
| 2024-511922-30-00 Trial register | A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome | Not stated | 2 | - | - |
| NCT03972488 Trial register | Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET | running, but no longer enrolling | - | 2019-06-03 | Posted |
| NCT06865677 Trial register | Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas | terminated before completion | - | 2025-03-10 | Posted |
| NCT05724134 Trial register | Pancreatic Clamp in NAFLD | completed | - | 2023-02-13 | - |
| 2025-521243-20-00 Trial register | A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose Range-finding, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALXN2 | Not stated | 2 | - | - |
| NCT07102056 Trial register | 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms | not yet recruiting participants | - | 2025-08-03 | - |
| NCT04125836 Trial register | A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly | completed | - | 2019-10-14 | - |
| NCT07262957 Trial register | Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and t | currently recruiting participants | - | 2025-12-04 | - |
| NCT03624517 Trial register | Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices | terminated before completion | - | 2018-08-10 | Posted |
| NCT05364944 Trial register | A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropanc | terminated before completion | - | 2022-05-04 | - |
| NCT00262470 Trial register | Treatment of Orthostatic Intolerance | running, but no longer enrolling | - | 2005-12-06 | - |
| NCT06881888 Trial register | Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema | not yet recruiting participants | - | 2025-03-18 | - |
| NCT07195500 Trial register | Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Pa | currently recruiting participants | - | 2025-08-29 | - |
| 2022-502703-30-00 Trial register | Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial) | Not stated | 4 | - | - |
| NCT03000946 Trial register | Prevention of Postoperative Pancreatic Fistula by Somatostatin | completed | - | 2016-12-22 | - |
| NCT04919226 Trial register | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP- | running, but no longer enrolling | - | 2021-06-01 | - |
| NCT05387603 Trial register | Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors. | currently recruiting participants | - | 2022-04-21 | - |
| NCT05459844 Trial register | A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs | running, but no longer enrolling | - | 2022-07-15 | - |
| NCT06193616 Trial register | Outcome of ADPKD With Octreotide LAR | running, but no longer enrolling | - | 2024-01-05 | - |
| NCT06345079 Trial register | Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours | currently recruiting participants | - | 2024-03-14 | - |
| NCT07104487 Trial register | [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease | currently recruiting participants | - | 2025-08-05 | - |
| NCT07057622 Trial register | A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs | currently recruiting participants | - | 2025-07-10 | - |
| NCT01673906 Trial register | 68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours | completed | - | 2012-08-28 | - |
| NCT03466216 Trial register | Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET | terminated before completion | - | 2018-01-11 | - |
| NCT06974344 Trial register | Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial) | not yet recruiting participants | - | 2025-05-15 | - |
| NCT03289741 Trial register | A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide | completed | - | 2017-09-21 | Posted |
| NCT04997317 Trial register | Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide | currently recruiting participants | - | 2021-07-19 | - |
| NCT06881628 Trial register | Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients | currently recruiting participants | - | 2025-03-04 | - |
| NCT03792555 Trial register | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) | completed | - | 2018-12-27 | Posted |
| NCT02457156 Trial register | Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy | completed | - | 2015-05-29 | - |
| NCT00463983 Trial register | Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide | completed | - | 2007-04-20 | - |
| NCT02795858 Trial register | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors | completed | - | 2016-06-07 | Posted |
| 2024-514225-30-00 Trial register | Phase 1, first-in-human trial to evaluate the safety, tolerability, and pharmacokinetics of ascending single oral doses of octreotide/ LipOra peptide in healthy | Not stated | 1 | - | - |
| 2024-510667-33-00 Trial register | A Phase 3, open-label, single-arm, multi-center trial to assess the long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly | Not stated | 3 | - | - |
| NCT02691078 Trial register | Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors | completed | - | 2016-02-25 | - |
| NCT02736448 Trial register | 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors | terminated before completion | - | 2016-04-07 | - |
| NCT06753630 Trial register | Polydeoxyribonucleotide for Elbow Lateral Epicondylitis | completed | - | 2024-12-31 | - |
| NCT04917484 Trial register | Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients | currently recruiting participants | - | 2021-06-08 | - |
| NCT05833217 Trial register | Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 | currently recruiting participants | - | 2023-04-26 | - |
| NCT04871204 Trial register | Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer | completed | - | 2021-05-04 | - |
| NCT06505395 Trial register | A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET | currently recruiting participants | - | 2024-07-17 | - |
| NCT06045260 Trial register | "Receptor Radionuclide Therapy With 177Lu-DOTATOC | currently recruiting participants | - | 2023-09-13 | - |
| NCT01424241 Trial register | Effects of Sandostatin LAR® in Acromegaly | completed | - | 2011-08-19 | Posted |
| NCT06126354 Trial register | Dexamethasone/Pancreatic Clamp P&F | withdrawn before enrolling anyone | - | 2023-11-13 | - |
| NCT05701241 Trial register | Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients | currently recruiting participants | - | 2023-01-05 | - |
| NCT05359146 Trial register | Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) | last verified some time ago; the register no longer confirms its status | - | 2022-04-27 | - |
| NCT01070758 Trial register | Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy | completed | - | 2010-02-18 | - |
| NCT03377660 Trial register | Resection of the Esophagus and Subsequent Weight Loss | terminated before completion | - | 2017-12-11 | - |
| NCT06300216 Trial register | A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors | not yet recruiting participants | - | 2024-03-08 | - |
| NCT04048707 Trial register | Angiotensin 2 for Hepatorenal Syndrome | withdrawn before enrolling anyone | - | 2019-08-07 | - |
| NCT03179995 Trial register | Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy | terminated before completion | - | 2017-06-07 | Posted |
| NCT06254235 Trial register | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | completed | - | 2024-02-12 | - |
| NCT03724409 Trial register | Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases | terminated before completion | - | 2018-10-25 | - |
| NCT02381249 Trial register | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | completed | - | 2015-03-06 | - |
| NCT02385617 Trial register | Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer | completed | - | 2015-03-11 | - |
| NCT06080204 Trial register | Real-world Study on Adjuvant Octreotide Therapy in pNETs | completed | - | 2023-10-12 | - |
| NCT06085976 Trial register | Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. | last verified some time ago; the register no longer confirms its status | - | 2023-10-17 | - |
| NCT05761431 Trial register | A Single-dose Study of Octreotide Injection in Healthy Adult Subjects | completed | - | 2023-03-09 | - |
| NCT06062719 Trial register | Role of Octreotide in Non Variceal Bleeding | last verified some time ago; the register no longer confirms its status | - | 2023-10-02 | - |
| NCT03044977 Trial register | Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors | running, but no longer enrolling | - | 2017-02-07 | - |
| NCT00427349 Trial register | AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors | completed | - | 2007-01-29 | Posted |
| NCT00003057 Trial register | Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer | completed | - | 2004-07-19 | - |
| NCT00003283 Trial register | Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma | completed | - | 2004-04-14 | - |
| NCT05894486 Trial register | Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin R | last verified some time ago; the register no longer confirms its status | - | 2023-05-30 | - |
| NCT02333565 Trial register | Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas | completed | - | 2015-01-07 | - |
| NCT02384122 Trial register | Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias | completed | - | 2015-03-10 | - |
| NCT04941911 Trial register | A Feasibility Study of Octreotide Infusion During Liver Transplant. | last verified some time ago; the register no longer confirms its status | - | 2021-06-28 | - |
| NCT05683444 Trial register | Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial | completed | - | 2023-01-13 | - |
| NCT03967249 Trial register | Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands | completed | - | 2019-05-23 | - |
| NCT04276597 Trial register | Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NE | withdrawn before enrolling anyone | - | 2020-02-14 | - |
| NCT02335580 Trial register | Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis | completed | - | 2015-01-07 | - |
| NCT04915144 Trial register | 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs | withdrawn before enrolling anyone | - | 2021-04-28 | - |
| NCT03273712 Trial register | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) | completed | - | 2017-09-06 | Posted |
| NCT03891849 Trial register | Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock | withdrawn before enrolling anyone | - | 2019-03-27 | - |
| NCT05682209 Trial register | The Effect of Octreotide on Wound Drainage After Mastectomy | completed | - | 2023-01-12 | - |
| NCT01538966 Trial register | Acromegaly Combination Treatment Study | terminated before completion | - | 2012-02-27 | Posted |
| 2022-502745-98-00 Trial register | Octreotide treatment to improve nutritional recovery after surgery for patients with esophageal or gastric cancer, a prospective randomized open label phase II | Not stated | 2 | - | - |
| NCT01613495 Trial register | Ghrelin Suppression by Octreotide in Prader-Willi | last verified some time ago; the register no longer confirms its status | - | 2012-06-07 | - |
| NCT04027348 Trial register | Palliative Management of Inoperable Malignant Bowel Obstruction | terminated before completion | - | 2019-07-22 | Posted |
| NCT01086982 Trial register | Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ® | suspended | - | 2010-03-15 | - |
| NCT03541447 Trial register | Tolvaptan-Octreotide LAR Combination in ADPKD | completed | - | 2018-05-30 | - |
| NCT01229943 Trial register | Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Can | completed | - | 2010-10-28 | Posted |
| NCT03791736 Trial register | Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation | terminated before completion | - | 2018-12-31 | - |
| NCT02010385 Trial register | Investigation of the Effects of Obesity Surgery on Appetitive Behaviour | completed | - | 2013-12-12 | - |
| NCT03741517 Trial register | Biomarker Study of Pancreatic Neuroendocrine Tumours | last verified some time ago; the register no longer confirms its status | - | 2018-11-09 | - |
| NCT05199038 Trial register | Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study | last verified some time ago; the register no longer confirms its status | - | 2022-01-20 | - |
| NCT03520569 Trial register | Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults | completed | - | 2018-05-09 | Posted |
| NCT02685709 Trial register | Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly | completed | - | 2016-02-19 | Posted |
| NCT05340192 Trial register | Effect of Octreotide on Saliva | completed | - | 2022-04-22 | - |
| NCT01578239 Trial register | A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut C | completed | - | 2012-04-16 | Posted |
| NCT03158090 Trial register | The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research | currently recruiting participants | - | 2017-05-06 | - |
| NCT04552847 Trial register | Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors | completed | - | 2020-09-17 | - |
| NCT05171751 Trial register | Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia | completed | - | 2021-12-29 | - |
| NCT03103009 Trial register | Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia | completed | - | 2017-03-31 | - |
| NCT01869725 Trial register | Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT | completed | - | 2013-05-31 | Posted |
| NCT02294006 Trial register | Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs | last verified some time ago; the register no longer confirms its status | - | 2014-11-19 | - |
| NCT00171730 Trial register | An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly | completed | - | 2005-09-13 | Posted |
| NCT04028323 Trial register | Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903) | last verified some time ago; the register no longer confirms its status | - | 2019-07-22 | - |
| NCT03734627 Trial register | Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery | completed | - | 2018-11-08 | - |
| NCT01619865 Trial register | Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors | completed | - | 2012-06-14 | Posted |
| NCT01789281 Trial register | Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. | completed | - | 2013-02-07 | Posted |
| NCT02973204 Trial register | Circulating Tumor Cells and Tumor DNA in HCC and NET | completed | - | 2016-11-25 | - |
| NCT00001849 Trial register | New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome | completed | - | 1999-11-03 | Posted |
| NCT04790708 Trial register | Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2) | last verified some time ago; the register no longer confirms its status | - | 2021-03-02 | - |
| NCT03455322 Trial register | Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1. | completed | - | 2018-03-06 | - |
| NCT03001349 Trial register | 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors | terminated before completion | - | 2016-12-20 | - |
| NCT03252353 Trial register | Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly | last verified some time ago; the register no longer confirms its status | - | 2017-08-17 | Posted |
| NCT04194125 Trial register | Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer | last verified some time ago; the register no longer confirms its status | - | 2019-12-07 | - |
| NCT01346098 Trial register | Islet Autotransplantation in Patients at Very High-risk Pancreatic Anastomosis | completed | - | 2011-04-29 | - |
| NCT02916433 Trial register | Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients | completed | - | 2016-09-27 | Posted |
| NCT03798912 Trial register | A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform | completed | - | 2019-01-10 | - |
| NCT04129255 Trial register | Octreotide LAR in the Induction of Immunologic Response in NENs Patients | completed | - | 2019-10-16 | - |
| NCT03883776 Trial register | Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors | completed | - | 2019-03-21 | - |
| NCT04522297 Trial register | Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome | completed | - | 2020-08-21 | - |
| NCT02032784 Trial register | Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding | terminated before completion | - | 2014-01-10 | - |
| NCT03197012 Trial register | Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor | completed | - | 2017-06-20 | - |
| NCT03112694 Trial register | Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors | completed | - | 2017-04-13 | - |
| NCT00092287 Trial register | Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome | terminated before completion | - | 2004-09-27 | - |
| NCT04353193 Trial register | Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial. | last verified some time ago; the register no longer confirms its status | - | 2020-04-20 | - |
| NCT00002864 Trial register | Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | completed | - | 2004-06-16 | - |
| NCT00171873 Trial register | Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut | completed | - | 2005-09-15 | Posted |
| NCT04296149 Trial register | Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe | completed | - | 2020-03-05 | - |
| NCT04281680 Trial register | Impact of Pasireotide on Postoperative Pancreatic Fistulas Following Distal Resections | completed | - | 2020-02-19 | - |
| NCT00226967 Trial register | Stress, Diurnal Cortisol, and Breast Cancer Survival | completed | - | 2005-09-13 | - |
| NCT00444873 Trial register | Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly | completed | - | 2007-03-08 | - |
| NCT02177773 Trial register | GA-68 DOTA-TOC of Somatostatin Positive Malignancies | terminated before completion | - | 2014-06-25 | Posted |
| NCT01865760 Trial register | Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia | completed | - | 2013-05-31 | - |
| NCT04140409 Trial register | Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation | terminated before completion | - | 2019-10-25 | - |
| NCT00781911 Trial register | A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer | completed | - | 2008-10-29 | Posted |
| NCT02437825 Trial register | Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery | last verified some time ago; the register no longer confirms its status | - | 2015-05-08 | - |
| NCT00216398 Trial register | Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR | completed | - | 2005-09-22 | - |
| NCT00234520 Trial register | A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreot | completed | - | 2005-10-07 | - |
| NCT02294786 Trial register | Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatmen | terminated before completion | - | 2014-11-19 | Posted |
| NCT03846180 Trial register | Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage | completed | - | 2019-02-19 | - |
| NCT03057509 Trial register | A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors | withdrawn before enrolling anyone | - | 2017-02-20 | - |
| NCT03571594 Trial register | A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers | terminated before completion | - | 2018-06-27 | - |
| NCT02123576 Trial register | Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline | terminated before completion | - | 2014-04-18 | Posted |
| NCT02396953 Trial register | Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acrom | completed | - | 2015-03-24 | Posted |
| NCT01587222 Trial register | Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure | withdrawn before enrolling anyone | - | 2012-04-30 | - |
| NCT00701363 Trial register | Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects | completed | - | 2008-06-19 | Posted |
| NCT03812939 Trial register | Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs | last verified some time ago; the register no longer confirms its status | - | 2019-01-23 | - |
| NCT01370161 Trial register | Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis | completed | - | 2011-06-07 | - |
| NCT00853047 Trial register | Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy | completed | - | 2009-02-27 | Posted |
| NCT03017690 Trial register | Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) | completed | - | 2017-01-11 | - |
| NCT03756116 Trial register | Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide | last verified some time ago; the register no longer confirms its status | - | 2018-11-28 | - |
| NCT00552071 Trial register | Ultrasound Guided Octreotide LAR Injection in Acromegaly | completed | - | 2007-11-01 | Posted |
| NCT03511768 Trial register | A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms | last verified some time ago; the register no longer confirms its status | - | 2018-04-30 | - |
| NCT02237053 Trial register | Effects of Glucagon Administration on Energy Expenditure | completed | - | 2014-09-11 | - |
| NCT02874326 Trial register | Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber | last verified some time ago; the register no longer confirms its status | - | 2016-08-22 | - |
| NCT01137682 Trial register | Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromega | completed | - | 2010-06-04 | Posted |
| NCT00966355 Trial register | Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding | completed | - | 2009-08-26 | Posted |
| NCT02488512 Trial register | Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas | terminated before completion | - | 2015-06-19 | - |
| NCT01677910 Trial register | TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) | completed | - | 2012-08-30 | Posted |
| NCT02217800 Trial register | The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics | completed | - | 2014-08-15 | Posted |
| NCT02235987 Trial register | Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. | completed | - | 2014-09-10 | Posted |
| NCT02021942 Trial register | Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size | completed | - | 2013-12-20 | Posted |
| NCT03398941 Trial register | The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, | last verified some time ago; the register no longer confirms its status | - | 2018-01-16 | - |
| NCT01377246 Trial register | Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency | completed | - | 2011-06-21 | - |
| NCT01567488 Trial register | Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET | completed | - | 2012-03-30 | - |
| NCT02299089 Trial register | Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) | completed | - | 2014-11-24 | Posted |
| NCT03061604 Trial register | RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding | completed | - | 2017-02-23 | - |
| NCT03013387 Trial register | Dosimetry Guided PRRT With 90Y-DOTATOC | withdrawn before enrolling anyone | - | 2017-01-06 | - |
| NCT02474914 Trial register | Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy | completed | - | 2015-06-18 | - |
| NCT01412424 Trial register | Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly | completed | - | 2011-08-09 | Posted |
| NCT00001228 Trial register | Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer | completed | - | 1999-11-04 | - |
| NCT00600886 Trial register | Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly | completed | - | 2008-01-25 | Posted |
| NCT03031535 Trial register | Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers | completed | - | 2017-01-25 | - |
| NCT02359500 Trial register | 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) | terminated before completion | - | 2015-01-23 | - |
| NCT02194452 Trial register | Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors | withdrawn before enrolling anyone | - | 2014-07-16 | - |
| NCT00182754 Trial register | Octreotide in Treating Patients With Cancer-Related Malignant Ascites | completed | - | 2005-09-16 | Posted |
| NCT00332969 Trial register | Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma | completed | - | 2006-06-02 | - |
| NCT00376064 Trial register | Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly | completed | - | 2006-09-14 | - |
| NCT01278342 Trial register | Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegali | completed | - | 2011-01-14 | Posted |
| NCT00171886 Trial register | Octreotide Efficacy and Safety in First-line Acromegalic Patients | completed | - | 2005-09-15 | - |
| NCT02374632 Trial register | Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass | last verified some time ago; the register no longer confirms its status | - | 2015-03-02 | - |
| NCT01707225 Trial register | Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) | completed | - | 2012-10-16 | Posted |
| NCT02668588 Trial register | Extended-release of Octreotide (LF-PB) for the Treatment of Seroma | completed | - | 2016-01-29 | - |
| NCT01618513 Trial register | Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target | completed | - | 2012-06-04 | - |
| NCT00223691 Trial register | Treatment of Orthostatic Hypotension in Autonomic Failure | completed | - | 2005-09-22 | - |
| NCT00002779 Trial register | Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma | completed | - | 2004-07-29 | - |
| NCT02977897 Trial register | Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide | last verified some time ago; the register no longer confirms its status | - | 2016-11-30 | - |
| NCT02375464 Trial register | Gallium-68 DOTATOC for Management of Neuroendocrine Tumors | no longer available | - | 2015-02-24 | - |
| NCT00088582 Trial register | Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients | completed | - | 2004-08-02 | - |
| NCT02920567 Trial register | Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion | last verified some time ago; the register no longer confirms its status | - | 2016-09-30 | - |
| NCT02195635 Trial register | Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects | completed | - | 2014-07-21 | - |
| NCT01371643 Trial register | Surgical Debulking of Pituitary Adenomas | completed | - | 2011-06-13 | Posted |
| NCT02668172 Trial register | Pasireotide LAR and Pegvisomant Study in Acromegaly | last verified some time ago; the register no longer confirms its status | - | 2015-12-07 | - |
| NCT01204476 Trial register | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | - | 2010-09-17 | - |
| NCT00033605 Trial register | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | completed | - | 2003-01-27 | - |
| NCT00049023 Trial register | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | - | 2003-01-27 | - |
| NCT01048086 Trial register | 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) | withdrawn before enrolling anyone | - | 2010-01-11 | - |
| NCT02111044 Trial register | Phase II Study With ITF2984 in Acromegalic Patients | completed | - | 2014-04-10 | - |
| NCT02119884 Trial register | Hemodynamic Effects of Terlipressin and High Dose Octreotide | completed | - | 2014-04-22 | - |
| NCT01755182 Trial register | Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors | terminated before completion | - | 2012-12-18 | - |
| NCT00241020 Trial register | Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma | completed | - | 2005-10-18 | - |
| NCT01860742 Trial register | Randomized Phase III of PRRT Versus Interferon | withdrawn before enrolling anyone | - | 2013-05-21 | - |
| NCT01121939 Trial register | Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers | completed | - | 2010-05-10 | Posted |
| NCT01917773 Trial register | Effect of Octreotide on the Colonic Motility in Pediatric Patients | completed | - | 2013-08-07 | Posted |
| NCT02631616 Trial register | Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET | last verified some time ago; the register no longer confirms its status | - | 2015-12-03 | - |
| NCT00432068 Trial register | Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers | completed | - | 2007-02-06 | - |
| NCT00075868 Trial register | Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer | completed | - | 2004-01-13 | - |
| NCT00227773 Trial register | Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | withdrawn before enrolling anyone | - | 2005-09-28 | - |
| NCT02012166 Trial register | A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insul | completed | - | 2013-12-16 | - |
| NCT00978211 Trial register | DOTA-TOC in Metastasized Neuroendocrine Tumors | completed | - | 2009-09-15 | - |
| NCT01157858 Trial register | Everolimus and LongActing Octreotide Trial in Polycystic Livers | completed | - | 2010-07-07 | - |
| NCT01480986 Trial register | IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC | completed | - | 2011-11-29 | - |
| NCT00582426 Trial register | Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea | completed | - | 2007-12-28 | Posted |
| NCT02427295 Trial register | Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues | last verified some time ago; the register no longer confirms its status | - | 2015-04-28 | - |
| NCT02409849 Trial register | Octreotide LAR as Maintenance Treatment for Patients With NEC | last verified some time ago; the register no longer confirms its status | - | 2015-04-07 | - |
| NCT01301222 Trial register | Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas | completed | - | 2011-02-23 | - |
| NCT01886287 Trial register | P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome | terminated before completion | - | 2013-06-25 | Posted |
| NCT01783899 Trial register | Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding | completed | - | 2013-02-01 | - |
| NCT02311608 Trial register | Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails | last verified some time ago; the register no longer confirms its status | - | 2014-12-08 | - |
| NCT02305069 Trial register | Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle | completed | - | 2014-12-02 | - |
| NCT01469338 Trial register | Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | terminated before completion | - | 2011-11-10 | - |
| NCT00412061 Trial register | Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor | completed | - | 2006-12-15 | Posted |
| NCT00742339 Trial register | Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome | terminated before completion | - | 2008-08-27 | - |
| NCT02217826 Trial register | Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173 | completed | - | 2014-08-15 | - |
| NCT02217839 Trial register | Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173 | completed | - | 2014-08-15 | - |
| NCT01029275 Trial register | Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone | completed | - | 2009-12-09 | - |
| NCT01754285 Trial register | Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea | completed | - | 2012-12-21 | - |
| NCT00399893 Trial register | Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) | terminated before completion | - | 2006-11-15 | Posted |
| NCT00002947 Trial register | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated before completion | - | 1999-11-01 | - |
| NCT00521300 Trial register | Preoperative Octreotide Treatment of Acromegaly | completed | - | 2007-08-27 | - |
| NCT02147470 Trial register | Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study | last verified some time ago; the register no longer confirms its status | - | 2013-12-17 | - |
| NCT00108355 Trial register | Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis | completed | - | 2005-04-15 | Posted |
| NCT00008073 Trial register | Octreotide and Doxorubicin in Treating Patients With Advanced Cancer | completed | - | 2004-05-24 | - |
| NCT00987168 Trial register | Sandostatine® LP and Hyperinsulinism | completed | - | 2009-09-29 | - |
| NCT00510224 Trial register | Sandostatin for Patients With Androgen Independent Prostate Cancer | terminated before completion | - | 2007-07-30 | Posted |
| NCT00765323 Trial register | Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly | terminated before completion | - | 2008-10-02 | - |
| NCT00884715 Trial register | Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome | terminated before completion | - | 2009-04-21 | - |
| NCT01295060 Trial register | Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly | terminated before completion | - | 2011-02-14 | - |
| NCT00690430 Trial register | Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease | completed | - | 2008-06-04 | Posted |
| NCT00002967 Trial register | Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer | completed | - | 2004-09-03 | - |
| NCT01871844 Trial register | ITF2984 Repeated Doses Study in Healthy Volunteers | completed | - | 2013-06-07 | - |
| NCT00363051 Trial register | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | - | 2006-08-15 | Posted |
| NCT00006368 Trial register | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | - | 2000-10-04 | - |
| NCT00006370 Trial register | Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer | completed | - | 2004-04-02 | - |
| NCT00309283 Trial register | Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study | completed | - | 2006-03-30 | - |
| NCT01561066 Trial register | Autologous Fibrin Glues for Fistulas Closure | completed | - | 2012-03-22 | - |
| NCT00426153 Trial register | Octreotide in Severe Polycystic Liver Disease | completed | - | 2007-01-24 | Posted |
| NCT00004895 Trial register | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | - | 2003-05-09 | - |
| NCT00088595 Trial register | Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors | completed | - | 2004-07-30 | Posted |
| NCT00006269 Trial register | Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | terminated before completion | - | 2004-05-24 | - |
| NCT00466856 Trial register | Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | terminated before completion | - | 2007-04-27 | - |
| NCT00248157 Trial register | Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopat | terminated before completion | - | 2005-11-03 | - |
| NCT00128232 Trial register | Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients | completed | - | 2005-08-09 | - |
| NCT00171613 Trial register | A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients | completed | - | 2005-09-15 | - |
| NCT00242541 Trial register | Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas | terminated before completion | - | 2005-10-20 | - |
| NCT00225979 Trial register | Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly | completed | - | 2005-09-26 | - |
| NCT00248131 Trial register | Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy o | terminated before completion | - | 2005-11-03 | - |
| NCT01400100 Trial register | Effects of Intraarterial Octreotide on Pancreatic Texture | completed | - | 2011-07-22 | - |
| NCT00257426 Trial register | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | completed | - | 2005-11-22 | - |
| NCT00652379 Trial register | Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients | completed | - | 2008-04-03 | - |
| NCT00130845 Trial register | Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy | completed | - | 2005-08-16 | - |
| NCT00131144 Trial register | Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy | completed | - | 2005-08-17 | - |
| NCT00332696 Trial register | Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | completed | - | 2006-06-02 | Posted |
| NCT00076362 Trial register | Pediatric Hypothalamic Obesity | completed | - | 2004-01-21 | - |
| NCT00222092 Trial register | Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers | completed | - | 2005-09-22 | - |
| NCT00913055 Trial register | Open Label Study of Octreotide Implant in Patients With Acromegaly | completed | - | 2009-06-03 | - |
| NCT00590343 Trial register | Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors | completed | - | 2007-12-26 | - |
| NCT00372697 Trial register | Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly | completed | - | 2006-09-07 | Posted |
| NCT01267669 Trial register | A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding | completed | - | 2010-12-27 | - |
| NCT00789841 Trial register | Gastrointestinal Motility in Patients With Neuroendocrine Tumors | completed | - | 2008-11-11 | - |
| NCT01203306 Trial register | Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors | last verified some time ago; the register no longer confirms its status | - | 2010-09-16 | - |
| NCT01188733 Trial register | Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis | completed | - | 2010-08-25 | - |
| NCT00005906 Trial register | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | completed | - | 2000-06-12 | Posted |
| NCT00642421 Trial register | Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients | terminated before completion | - | 2008-03-21 | - |
| NCT00250796 Trial register | Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma | completed | - | 2005-11-08 | - |
| NCT00050635 Trial register | STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea | completed | - | 2002-12-17 | - |
| NCT00166725 Trial register | Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients | completed | - | 2005-09-14 | - |
| NCT01014793 Trial register | Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients | completed | - | 2009-11-17 | - |
| NCT00990535 Trial register | High Dose Somatostatin Analogues in Neuroendocrine Tumors | completed | - | 2009-10-07 | - |
| NCT00094146 Trial register | Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity | completed | - | 2004-10-14 | - |
| NCT00495846 Trial register | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma | completed | - | 2007-07-03 | - |
| NCT00953394 Trial register | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | completed | - | 2009-08-06 | - |
| NCT00635765 Trial register | Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients | completed | - | 2008-03-11 | - |
| NCT00584298 Trial register | Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide | completed | - | 2008-01-02 | - |
| NCT00804297 Trial register | Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia | completed | - | 2008-12-08 | - |
| NCT00616551 Trial register | Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients | completed | - | 2008-02-15 | - |
| NCT00170742 Trial register | Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulatio | terminated before completion | - | 2005-09-15 | - |
| NCT00703079 Trial register | Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly | completed | - | 2008-06-23 | - |
| NCT00068029 Trial register | Pegvisomant And Sandostatin LAR Combination Study | completed | - | 2003-09-04 | - |
| NCT00068042 Trial register | A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly | completed | - | 2003-09-04 | - |
| NCT00595140 Trial register | Acute Application of Pegvisomant and Octreotide in Acromegaly | completed | - | 2008-01-16 | - |
| NCT00001860 Trial register | Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | completed | - | 1999-11-03 | - |
| NCT00616408 Trial register | Prediction of Tumor Shrinkage in Acromegaly | completed | - | 2008-02-15 | - |
| NCT00615004 Trial register | Cardiovascular Outcome After Surgery or Somatostatin Analogues | completed | - | 2008-02-01 | - |
| NCT00240045 Trial register | The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction | completed | - | 2005-10-17 | - |
| NCT00534677 Trial register | The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed | completed | - | 2007-09-26 | - |
| NCT00175305 Trial register | Prader-Willi Syndrome and Appetite | terminated before completion | - | 2005-09-09 | - |
| NCT00461149 Trial register | Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly | completed | - | 2007-04-17 | - |
| NCT00274170 Trial register | Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache | last verified some time ago; the register no longer confirms its status | - | 2006-01-10 | - |
| NCT00386984 Trial register | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | - | 2006-10-12 | - |
| NCT00145405 Trial register | Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction | completed | - | 2005-09-05 | - |
| NCT00002252 Trial register | A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquire | completed | - | 2001-08-31 | - |
| NCT00002253 Trial register | A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficienc | completed | - | 2001-08-31 | - |
| NCT00004327 Trial register | Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectas | completed | - | 1999-10-19 | - |
Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.